Rights and permissions
About this article
Cite this article
NCI tamoxifen trial should resume says FDA. React. Wkly. 510, 2 (1994). https://doi.org/10.2165/00128415-199405100-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-199405100-00004